Page last updated: 2024-10-26

thiorphan and Kidney Failure, Chronic

thiorphan has been researched along with Kidney Failure, Chronic in 2 studies

Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dussaule, JC1
Michel, C1
Peraldi, MN1
Lecomte, JM1
Gros, C1
Mignon, F1
Ardaillou, R1
Hand, MF1
Haynes, WG1
Webb, DJ1

Trials

2 trials available for thiorphan and Kidney Failure, Chronic

ArticleYear
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
    Clinical science (London, England : 1979), 1993, Volume: 84, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cyclic GMP; Double-Blind Method; Female;

1993
Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Kidney international, 1999, Volume: 55, Issue:2

    Topics: Adult; Endothelin Receptor Antagonists; Endothelin-1; Female; Forearm; Glycopeptides; Humans; Inject

1999